NEHEN March Meeting: What's Hot in Healthcare Investing

Presented By New England Healthcare Executives


Emerging Enterprise Center at Foley Hoag

Bay Colony Corporate Center, North Entrance
1000 Winter Street - Suite 4000
Waltham, MA 02451

Directions »


March 11, 2013 7:30AM–10:00AM


Update and outlook for Venture capital, Private Equity and Debt Equity Investments in healthcare.

The Investment Landscape for Healthcare Services and Life Sciences companies has changed dramatically.  Boston is leading hub for the health IT, biotech and medtech industry.  Seed/early stage financing and the number of new startups continue to flourish in our community.  This panel will present to the audiences an overview of the current state of healthcare services, health IT and bioscience venture capital, debt and private equity.   

Program topics include:

  • What are the current trends driving healthcare investments?
  • How will healthcare investing be affected by the implementation of the Affordable Care Act?  
  • How is the investment community responding to the challenges of debt-ridden community hospitals and Medicare & Medicaid cuts?
  • How will changes in reimbursement policies affect healthcare business models?
  • How will these market changes affect healthcare services investments in 2013 and beyond?
  • Who will dominate healthcare deal-making: strategic or financial buyers?

Program Moderator:

Maria Malavenda, Senior Partner Konnected Advisors, LLC

Maria Malavenda is the Founder and Managing Partner, KONNECTED Advisors, focuses her expertise on advising global businesses from start-ups and venture capital firms to the Fortune 50 on innovation, strategy, organizational and operational improvements. Maria has brought together consulting, capital fundraising and concept incubation under one organization. In addition to her experience as an entrepreneur and a senior executive in multi-national corporations which include, Deloitte, Accenture, and Johnson & Johnson, she has served as a strategist, coach, and consultant to a variety of organizations of all sizes and across all sectors.

Maria holds degrees from Brown University, The University of Connecticut School of Business, and attended Harvard Business School’s Executive Series.  


William M. deGroot, Principal, Boston Millennia Partners

Mr. de Groot joined Boston Millennia Partners in August of 2008. He has worked on international, federal and state public policy issues for healthcare companies including GlaxoSmithKline, Novartis and Millennium Pharmaceuticals. Mr. de Groot has had an extensive career in the public policy arena working both inside and outside of the government sector. This work was focused on driving legislation/regulation that allowed for a more streamlined delivery of products, services and overall healthcare to patients.

Mr. de Groot also brings a comprehensive network of corporate relationships from both the public and private sector. He has been active in a variety of business organizations including the Massachusetts Biotechnology Council, the New England Council, the Greater Philadelphia Chamber of Commerce, the Boston Chamber of Commerce, the Healthcare Institute of New Jersey, the St. Louis Regional Chamber and Growth Association, the Biotechnology Industry Organization (BIO) and the Pharmaceutical Researcher and Manufactures of America (PHRMA).

Mr. de Groot is a graduate of La Salle University in Philadelphia, Pennsylvania and holds an MBA from the University of Chicago Graduate School of Business.  

Derek H. Lee, Advisor, Athyrium Capital Management, LLC 

Mr. Lee joined Athyrium in 2012 and currently serves as an Advisor with a focus on sourcing and identifying opportunities through his broad and deep network across the healthcare sector.  Mr. Lee has more than 15 years of experience in Life Sciences investments across Therapeutics, Devices, Diagnostics and Services / HCIT as an Investment Banker, Venture Capitalist, Entrepreneur and Hedge Fund Analyst.  Mr. Lee specializes in structuring and implementing creative and complex deal structures and working closely with management teams on financing and exit strategies.

Prior to Athyrium, Mr. Lee was a Senior Analyst with Burrage Capital, a Life Sciences focused long-short equity fund.  Previously, Mr. Lee was the Chief Financial and Corporate Development Officer at Talaris Advisors, a biotech accelerator that leverages a strategic drug development discipline to minimize risk and cost while optimizing the odds of success in drug development portfolios.  Before founding Talaris Advisors, Mr. Lee Derek was a Principal with SV Life Sciences (SVLS), a leading healthcare focused venture capital advisor with approximately $2B under management. 

As an investment banker, Mr. Lee was with the Global Healthcare Group at UBS Warburg where he engaged in a variety of equity and M&A transactions in the life sciences sector. Prior to joining UBS Warburg, Derek was in the Healthcare Investment Banking Group at Salomon Smith Barney. Derek received his BS Finance from Bentley College.  

Gregg Osenkowski, Vice President, Sverica International

Gregg Osenkowski is a Vice President in the Boston office. He joined Sverica in 2006 and focuses on Sverica's investments in healthcare. Mr. Osenkowski is an observer to the board of directors of Center for Wound Healing, Inc.

He was previously with Greenwich Strategy a boutique strategy consulting firm in Providence, RI. At Greenwich Strategy, Mr. Osenkowski conducted due diligence for private equity transactions and consulted to firms in various industries including: business services, manufacturing and technology.

Mr. Osenkowski is a summa cum laude graduate of Northeastern University, where he earned a dual degree in finance and economics. He also holds a graduate degree in economics from New York University. He lives south of Boston with his wife and children. 

Jeremy Sohn, Managing Director, MPM Capital LLC

Jeremy Sohn joined MPM Capital’s Boston Office in 2013 as Managing Director to help lead the firm’s interests in mobile health and big data. Prior to MPM, Jeremy provided strategy and operations consulting for multiple healthcare and technology start-up companies. From 2007-2011, Jeremy was COO / VP of Strategy & Corporate Development for North Plains Systems, where he helped lead the company’s growth and eventual sale to Accel-KKR. In 2000, he co-founded an operating system and software-storage company, Wasabi Systems, and led the company’s worldwide Business Development activities. Throughout his career, Jeremy has also held various healthcare investment and consulting positions with Riverside Partners, Shattuck Hammond Partners (now Morgan Keegan), and The Lewin Group. Jeremy graduated cum laude from Princeton University's Woodrow Wilson School of Public and International Affairs, with a focus on biotechnology and medical policy.